Uniferon launched in the US

July 6, 2011

We're proud to announce that Uniferon® 100 and Uniferon® 200 is now available on the US market.

As distribution partner in the US, Pharmacosmos has appointed Ivesco, a major distribution company which has serviced the swine industry for more than 50 years.

Launch of Uniferon ends US vet iron shortages

Pharmacosmos has been supplying the US market with high quality, FDA approved raw materials in iron dextran since the early 1980s, but supplies of veterinary injectable iron dextran products in the US have been inconsistent in recent years due to the problems associated with previous manufacturers to consistently meet FDA requirements.

The FDA approval and subsequent US launch of Uniferon should effectively end these shortages.

Pharmacosmos is of course committed to the high standards of FDA compliance and looks forward to ensure an uninterrupted supply of US domestically manufactured quality veterinary iron. This way, regular buying patterns can be re-established for American swine producers and veterinarians.

Strengthened global position

The US is one of the world's largest markets for swine production with breeding stock about 5.8 million head and pig production of 115 million head annually.

President and CEO of Pharmacosmos A/S, Lars Christensen, states that this is a crucial step for Pharmacosmos and Uniferon:

"Uniferon's expansion into the US solidifies our position as world leading specialists in iron therapy - especially since Uniferon® 200 is now the only 200 mg/ml veterinary iron supplement that is approved by both the US Food and Drug Administration (FDA) and by health authorities in Europe and Asia."

"All in all, this brings us one step closer to our goal of global brand leadership."

See the new US advert for Uniferon here.

About Uniferon

Uniferon is a modern improved iron hydrogenated dextran based on a natural formula, which is approved for global use:

Uniferon is manufactured without the use of any organic solvents or cyanide, thus, avoiding trace residues of these impurities. Pharmacosmos manufactures iron dextran of high quality and unique purity for customers worldwide. Uniferon is the only injectable iron brand for piglets approved in the EU, the US and Asia.

About Pharmacosmos

Headquartered in Denmark, Pharmacosmos is a family-owned, international healthcare company with more than 50 years of innovation and leadership in iron- and carbohydrate-based treatments and solutions for human and animal use.

A research-based company, its ongoing R&D programme focuses on improving the lives of patients with iron deficiency with or without anaemia. More than 1 billion people live with iron deficiency anaemia and it is the leading cause of death for an estimated 180,000 people every year. This makes it one of the largest global health challenges of our time.

Pharmacosmos has subsidiaries in the Nordics, the UK and the US and its products are marketed in more than 80 countries across the world. Its manufacturing facilities are approved, among others, by the Danish Medicines Agency and the US FDA.